| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000016062 |
| Receipt No. | R000018666 |
| Official scientific title of the study | Utility of rapid on-site cytological evaluation during Endobrohchial ultrasound-guided transbronchial needle aspiration |
| Date of disclosure of the study information | 2015/01/15 |
| Last modified on | 2017/07/28 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Utility of rapid on-site cytological evaluation during Endobrohchial ultrasound-guided transbronchial needle aspiration | |
| Title of the study (Brief title) | Utility of ROSE during EBUS-TBNA | |
| Region |
|
|
| Condition | ||
| Condition | diseases causeing hilar and mediastinal lymphadenopathy (malignancy, sarcodosis, etc) | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim of this study was to explore the utility of Rapid on-site cytological evaluation (ROSE) during endobronchial ultrasound-guided needle aspiration (EBUS-TBNA) |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | diagnostic yields |
| Key secondary outcomes | the length of the examination for EBUS-TBNA, the number of needle aspirations per patient, complications, and additional examinations needed |
| Base | |
| Study type | Others,meta-analysis etc |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | patients who had undergone EBUS-TBNA for the diagnosis of mediastinal and/or hilar lymphadenopathy | |||
| Key exclusion criteria | none | |||
| Target sample size | 51 | |||
| Research contact person | |
| Name of lead principal investigator | Mari Yamasue |
| Organization | Oita university faculty of medicine |
| Division name | Department of respiratory medicine and infectious diseases |
| Address | Hasama-machi Idaigaoka 1-1, Yufu-city, Oita, Japan |
| TEL | 097-586-5804 |
| sai-mari@oita-u.ac.jp | |
| Public contact | |
| Name of contact person | Mari Yamasue |
| Organization | Oita university faculty of medicine |
| Division name | Department of respiratory medicine and infectious diseases |
| Address | Hasama-machi Idaigaoka 1-1, Yufu-city, Oita, Japan |
| TEL | 097-586-5804 |
| Homepage URL | |
| sai-mari@oita-u.ac.jp | |
| Sponsor | |
| Institute | Oita university faculty of medicine, Department of respiratory medicine and infectious diseases |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Oita university faculty of medicine, Department of respiratory medicine and infectious diseases |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 大分大学医学部附属病院 呼吸器内科 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | This study is a retrospective analysis of patients who had undergone EBUS-TBNA for the diagnosis of mediastinal and (or) hilar lymphadenopathy between January 2012 and November 2014. We compare the following points between the groups of patients who underwent EBUS-TBNA with or without ROSE. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000018666 |